Laboratorios Farmaceuticos Rovi, S.A.
LABFFHealthcare · Stock · annual payer
$90.61
Add to PortfolioForward Yield
2.40%
Annual Dividend
$2.18
Payout Ratio
0%
5-Yr Growth
—
Ex-Date
Jul 13, 2026
Frequency
Annual
LABFF Dividend Safety Score
47/ 100
Grade D
Risky
Dividend-growth streak0 consecutive years of growth
Cut historyCut its dividend in 2025
Earnings payout coverageNegative earnings
Balance-sheet strengthDebt/equity of 0.17
Yield vs its historyYield in line with its history
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Is LABFF a good dividend stock?
MixedLaboratorios Farmaceuticos Rovi, S.A. (LABFF) pays a annual dividend yielding 2.40% ($2.18/yr), with 0 years of growth and a dividend-safety grade of D. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.
Advantages
Risks
- Cut its dividend in 2025
- Below-average dividend safety score
Key Data
- Dividend Yield
- 2.40%
- Payout Ratio
- 0%
- Annual Dividend
- $2.18
- 5-Yr Avg Growth
- —
- Ex-Dividend Date
- Jul 13, 2026
- Years of Growth
- 0
- Frequency
- annual
- Beta
- 0.22
- Market Cap
- $4.6B
- P/E Ratio
- 28.9
- 5-Yr Total Return
- 34%
- 52-Week Range
- $90.61 – $90.61
- Dividend Safety
- D · 47/100
- Ever Cut?
- Yes (2025)
Frequently Asked Questions
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| Jul 14, 2025 | — | $1.0890 | regular |
| Jul 14, 2025 | — | $1.0885 | regular |
| Jul 8, 2024 | — | $1.2847 | regular |
| Jul 3, 2023 | — | $1.5060 | regular |
| Jul 5, 2022 | — | $1.1123 | regular |
| Jul 6, 2021 | — | $0.4437 | regular |
Income Calculator
At $2.18 / yr per share
Per payment (annual)$217.74
Annual$217.74
Monthly avg$18.15
